• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Roberto Ferrara, Laura Mezquita, +25 authors Caroline Caramella
  • Medicine
  • JAMA oncology
  • 2018 (First Publication: 1 November 2018)
  • Importance Hyperprogressive disease (HPD) is a new pattern of progression recently described in patients with cancer treated with programmed cell death 1 (PD-1) and programmed cell death ligand 1Continue Reading
  • Laura Mezquita, Edouard Auclin, +19 authors Benjamin Besse
  • Medicine
  • JAMA oncology
  • 2018 (First Publication: 11 January 2018)
  • Importance Derived neutrophils/(leukocytes minus neutrophils) ratio (dNLR) and lactate dehydrogenase (LDH) level have been correlated with immune checkpoint inhibitor (ICI) outcomes in patients withContinue Reading
  • Michele Simbolo, Andrea Mafficini, +18 authors Aldo Scarpa
  • Biology, Medicine
  • The Journal of pathology
  • 2017 (First Publication: 1 November 2016)
  • Next-generation sequencing (NGS) was applied to 148 lung neuroendocrine tumours (LNETs) comprising the four World Health Organization classification categories: 53 typical carcinoid (TCs), 35Continue Reading
  • Mario Caccese, Roberto Ferrara, +9 authors Emilio Bria
  • Medicine
  • Expert opinion on pharmacotherapy
  • 2016 (First Publication: 21 November 2016)
  • INTRODUCTION The treatment of patients with ALK-rearranged non-small-cell lung cancer was completely revolutionized by the introduction of Crizotinib, a small molecule inhibiting ALK, MET and ROS1.Continue Reading